Related by context. Frequent words. (Click for all words.) 85 Completes Enrollment 84 Drug Candidate 84 FDA Clears 83 Presents Positive 83 FDA Accepts 81 Receives FDA Clearance 80 Phase III Clinical Trial 80 Patient Enrollment 79 Clinical Trial Results 79 Initiates Phase 79 Announces Initiation 79 submitted Biologics License 78 Preclinical Data 78 Patent Covering 78 Initiate Phase 78 Receives Patent 78 Generic Version 77 Recombinant Human 77 Patent Issued 77 Shows Promise 76 Phase III Trial 76 Awarded Patent 76 Significantly Reduces 76 Achieves Milestone 76 Files Patent 75 Announces Publication 75 Pivotal Phase III 75 Study Demonstrates 75 Pivotal Trial 75 Signs Licensing Agreement 75 RNAi Therapeutics 75 Small Molecule 75 FDA Approves 75 Reduces Risk 75 FDA Clearance 75 Pivotal Phase 74 Cholesterol Drug 74 Receives Positive 74 Commercialize 74 Inc Therapeutic Competitors 73 Monoclonal Antibody 73 submitted Marketing Authorization 73 Announces Presentation 73 Announce Collaboration 73 Announces Issuance 73 Patent Lawsuit 73 Develop Next Generation 73 Inhibits 72 Well Tolerated 72 Exclusive License 72 Announces Successful Completion 72 Acquires Exclusive 72 Reports Positive 72 Drug Resistant 72 Low Dose 72 Regains Compliance 72 Receives CE 72 MKC# 72 Introduces Next Generation 71 Launches Next Generation 71 Secures Additional 71 Pulmonary Arterial Hypertension 71 Regains Compliance With 71 Holds Promise 71 Metastatic Melanoma 71 Announces Positive 71 Panzem R 71 Chronic Hepatitis C 71 Introduces Enhanced 71 Benign Prostatic Hyperplasia 71 Exploit collaboration 71 Announce Availability 71 Study Indicates 71 COMUNICADO 71 Receives Regulatory 71 Aliskiren 71 Blood Thinner 70 Unveils Innovative 70 Combination Therapy 70 Protects Against 70 Q2 Loss Narrows 70 Q1 Loss Narrows 70 CHEAP ONLINE PHARMACY LOW 70 Provides Guidance 70 Malaria Vaccine 70 Discontinues 70 Patients Treated 70 Positive Opinion 70 Strengthens Its 70 k Clearance 70 Provide Comprehensive 70 Completes Initial 70 R sorafenib tablets 70 FDA Warns 70 Study Confirms 70 Completes Tender Offer 70 Q3 Loss Narrows 70 Finalizes Acquisition 69 Increases Risk 69 Begins Shipping 69 Receives Notice